Search
for

    Research 10 of 1000+

    1. Rates of Infections, Malignancies, Cardiovascular Outcomes, and Death in Individuals with Hospital-treated Alopecia Areata: A Registry-based Cohort Study in Denmark Acta Dermato Venereologica · 2025
    2. Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome? Human Reproduction · 2004 · 38 citations
    3. Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen Clinical Endocrinology · 2015 · 45 citations
    4. DHEA : why, when, and how much ? D’après la conférence de Bruno Allolio (Wuerzburg), 50e Journées internationales d’endocrinologie clinique Henri-Pierre KLOTZ, septembre 2007 Annales D Endocrinologie · 2009
    5. Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth International journal of reproductive medicine · 2014 · 222 citations
    6. Transmasculine Hormone Therapy Endocrinology and Metabolism Clinics of North America · 2019 · 6 citations
    7. Minoxidil Elsevier eBooks · 2015
    8. Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population Frontiers in Endocrinology · 2021 · 15 citations
    9. Protective cardiovascular and renal actions of vitamin D and estrogen Frontiers in bioscience · 2012 · 13 citations
    10. [Efficacy and cardiovascular tolerability of minotricon in the treatment of seborrheic alopecia]. PubMed · 1990
    All research results →

    Community 2 of 21

    1. Pattern hair loss before the age of 35 is associated with higher chances of prostate cancer, cardiovascular diseases, and metabolic syndrome later in life Reddit · 7 Jun 2026
    2. Has anyone figured out what causes the cardiovascular issues with RU? Reddit · 23 Apr 2025
    All community results →

    Learn

    — no results

    Try a deeper search in learn →